logo
Denis Villeneuve to helm next James Bond adventure

Denis Villeneuve to helm next James Bond adventure

UPI4 days ago

1 of 2 | Denis Villeneuve arrives on the red carpet at the 2025 Writers Guild Awards New York Ceremony at Edison Ballroom on February 15. He has been tapped to direct the next James Bond movie. File Photo by John Angelillo/UPI | License Photo
June 26 (UPI) -- Prisoners, Sicario, Blade Runner: 2049 and Dune director Denis Villeneuve has signed on to helm Amazon MGM Studios' next James Bond adventure.
Tanya Lapointe will serve as executive producer, while Amy Pascal and David Heyman will serve as producers, according to the official James Bond X feed.
"Denis Villeneuve has been in love with James Bond movies since he was a little boy," Pascal and Heyman said in a joint statement Wednesday.
"It was always his dream to make this movie, and now it's ours, too," they added. "We are lucky to be in the hands of this extraordinary filmmaker."
Daniel Craig played the British secret agent in five blockbusters, starting with Casino Royale in 2006.
His final outing as the spy was 2021's No Time to Die, but no successor has been named.
No release date or title have been announced yet either.
Harrison Ford attends Japan premiere of 'Blade Runner 2049'
Harrison Ford reprises his role as Rick Deckard in the sequel. | License Photo

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

BBC apologizes for streaming Bob Vylan's 'antisemitic' Glastonbury set
BBC apologizes for streaming Bob Vylan's 'antisemitic' Glastonbury set

UPI

time39 minutes ago

  • UPI

BBC apologizes for streaming Bob Vylan's 'antisemitic' Glastonbury set

Bobby Vylan performs on the West Holts Stage at the 2025 Glastonbury Festival in Glastonbury on Saturday. Photo by Hugo Philpott/UPI | License Photo June 30 (UPI) -- The BBC has apologized for live-streaming Bob Vylan's Glastonbury Music Festival set over the weekend, calling it "deeply offensive" and "antisemitic." The British rap duo -- comprised of artists Bobby Vylan and Bobbie Vylan -- led the concertgoers, some of whom were waving Palestinian flags, in chants of "Death, death to the IDF," "From the river to the sea" and "Free, free Palestine" at the high-profile event, according to video posted on Bobby's Instagram account. After receiving expressions of what he described as being of both "support and hatred" over the weekend, Bobby doubled down on his message with an Instagram post Sunday, stating, "I said what I said." But the BBC is expressing regret over sharing the duo's festival performance with a global audience. "Millions of people tuned in to enjoy Glastonbury this weekend across the BBC's output but one performance within our live-streams included comments that were deeply offensive. The BBC respects freedom of expression, but stands firmly against incitement to violence. The antisemitic sentiments expressed by Bob Vylan were utterly unacceptable and have no place on our airwaves. We welcome Glastonbury's condemnation of the performance," the BBC said in a lengthy statement Monday. "The performance was part of a live stream of the West Holts stage on BBC iPlayer. The judgment on Saturday to issue a warning on screen while streaming online was in line with our editorial guidelines. In addition, we took the decision not to make the performance available on demand. The team were dealing with a live situation but with hindsight we should have pulled the stream during the performance. We regret this did not happen," the statement continued. "In light of this weekend, we will look at our guidance around live events so we can be sure teams are clear on when it is acceptable to keep output on air."

Kim Jong Un meets Russian culture minister amid growing ties
Kim Jong Un meets Russian culture minister amid growing ties

UPI

time2 hours ago

  • UPI

Kim Jong Un meets Russian culture minister amid growing ties

Russian Culture Minister Olga Lyubimova (2nd row 2-L) and North Korean leader Kim Jong Un (2nd row C) attend a performance in Pyongyang on Sunday. Lyubimova is visiting on the first anniversary of the signing of a North Korea-Russia comprehensive partnership treaty, state-run media reported Monday. Photo by KCNA/EPA-EFE SEOUL. June 30 (UPI) -- North Korean leader Kim Jong Un met with visiting Russian Culture Minister Olga Lyubimova in Pyongyang as the two countries continue to strengthen bilateral ties, the North's state-run media reported Monday. The meeting took place on Sunday at the headquarters of the ruling Workers' Party of Korea's Central Committee and was also attended by Russian Ambassador to North Korea Alexandr Matsegora, the official Korean Central News Agency reported. Lyubimova led a ministry delegation to mark the first anniversary of the countries' comprehensive strategic partnership treaty, under which North Korea has sent troops and weapons to Moscow to aid in its war against Ukraine. Kim said that "extensive and profound exchanges and cooperation in all fields are further expanding and developing day by day" in the wake of the partnership, according to KCNA. "It is important for the cultural sector to guide the relations between the two countries," he said. "It is necessary to further expand the exchange and cooperation in the field of culture and art to know well about each other's excellent cultural traditions and learn more." Lyubimova said her visit came at a time when the "solidity and invincibility of the DPRK-Russia friendship and solidarity are being more clearly proved," KCNA reported. The Democratic People's Republic of Korea is the official name of North Korea. "Cooperation between the two countries in the cultural field has reached the highest level in history," she added. The two discussed future plans for cultural exchanges and attended a concert by North Korean musicians and a visiting troupe of Russian performers, the KCNA report said. Photos released by KCNA showed images of North Korean troops deployed to Russia used as a stage backdrop. North Korea has sent some 14,000 troops to help Russia recapture lost territory in Kursk Province from Ukrainian forces, according to a recent report from the 11-country Multilateral Sanctions Monitoring Team. Pyongyang acknowledged sending the troops for the first time in April. The cultural meeting came on the heels of a pair of visits by Russia's Security Council Secretary Sergei Shoigu this month. On June 18, Shoigu announced that North Korea would send 6,000 military workers and combat engineers to help rebuild the Kursk region. North Korea is likely to send additional troops to support Russia's war against Ukraine in July or August, South Korea's National Intelligence Service told lawmakers in a closed-door meeting on Thursday.

'Inverse' vaccines may hold key to challenge autoimmune diseases
'Inverse' vaccines may hold key to challenge autoimmune diseases

UPI

time4 hours ago

  • UPI

'Inverse' vaccines may hold key to challenge autoimmune diseases

1 of 3 | Reverse or inverse vaccines work differently from conventional immunizations like the flu shot and currently available immunosuppressant treatments for autoimmune conditions. Photo by RF._.studio/ Pexels NEW YORK, June 30 (UPI) -- For the millions of Americans battling autoimmune disorders, new hope may be on the horizon in the form of reverse or inverse vaccines -- injections that target a specific part of the immune system. experts told UPI. However, these injections work differently from conventional immunizations like the flu shot and currently available immunosuppressant treatments for autoimmune conditions. They work by targeting only the specific part of the immune system that's behind diseases such as lupus, multiple sclerosis, psoriasis, rheumatoid arthritis and Type 1 diabetes, the experts say. "Inverse vaccines are being developed to treat undesired immune responses, [and] for these situations, the body is reacting to something that is not dangerous," said Lonnie Shea, a researcher in biomedical engineering at the University of Michigan who has studied inverse vaccines and worked on some of the key technology behind them. "A vaccine activates an immune response to a specific antigen," Shea told UPI via email. Inverse vaccines are being developed to treat undesired immune responses, [and] for these situations, the body is reacting to something that is not dangerous. Essentially, an inverse vaccine "aims to decrease the response to a specific antigen, like insulin in Type 1 diabetes," he added. First line of defense When healthy, the immune system is the body's first line of defense against diseases such as cancer and infections caused by viruses and bacteria, according to the National Institutes of Health. However, if the immune system isn't working properly, it can erroneously attack healthy cells, tissues and organs, causing autoimmune diseases that can affect any part of the body, weakening function and potentially leading to death, the NIH says. More than 80 autoimmune diseases are known, some of which are caused by exposure to environmental toxins and have no discovered cure. At least 15 million people in the United States, or about 5% of the population, have an autoimmune disease, the agency reports. Although no cure exists for these conditions, symptoms can be managed with drugs called immunosuppressants, which as the name suggests "broadly reduces your immune system response," Shea said. These drugs, which are typically administered via monthly injections, can have significant side effects, including making those taking them more susceptible to infections, according to the NIH. Many people taking them also have to be careful taking traditional vaccines, such as flu shot or COVID-19 shots because of their impact on the immune system. Training the immune system Developed by researchers at the University of Chicago and elsewhere, inverse vaccines use synthetic nanoparticles attached to specific disease-related proteins, or antigens, to train certain parts of the immune system to behave differently, limiting the attacks that cause autoimmune diseases, neurologist Dr. Lawrence Steinman said. With the inverse vaccines currently being studied, the nanoparticles are designed to mimic human cell death, which is a normal process in the human body, according to the 2021 study that first documented their effectiveness in people with celiac disease, another autoimmune disorder. Dying cells are considered foreign bodies, but the human immune system knows not to attack them. As a result, with the nanoparticles in inverse vaccines, the immune system can be trained not to attack them, or the proteins attached to them, which effectively short-circuits the process behind autoimmune diseases, Steinman said. "Instead of immunizing the recipient to a viral infection, the inverse vaccine tolerizes the immune system, so it will not attack our own tissues," Steinman, who has written about inverse vaccines, told UPI in an email. Several companies are running clinical trials of inverse vaccines, including Cour Pharma, which recently completed successful phase 2 clinical trials for their use in celiac disease and another autoimmune disease, primary biliary cholangitis, according to Shea at the University of Michigan, one of the researchers who started the company. Additional trials -- phase 2 studies are the second stage in the drug research and development process -- are starting for myasthenia gravis and Type 1 diabetes, he added. Although more research is needed before the shots become available, a process that could take five years or more, inverse vaccines offer key advantages, Shea said. For example, unlike immunosuppressants with their monthly dosing, the effects of inverse vaccines appear to last longer, perhaps for as much as a year, similar to conventional vaccines, research suggests. They may also work for people with severe, life-threatening allergies, such as peanut allergies, according to Shea, who has published a study in this area using mice. However, there's also the "risk that instead of tolerizing the human immune system to the target, the process induces conventional immunization, which would make autoimmune conditions like Type 1 diabetes and multiple sclerosis worse," Steinman said. However, "We have come close to success in some early-stage trials," he said "Thus far, none of the results are sufficiently robust for submission in the FDA approval process."

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store